MNAD Hypothesis Based Protocol Proposed for Treatment of COVID.19: Assessment of Minocycline, N. acetylcysteine, Aspirin & vitamin D (MNad) Theory for treatment of COVID.19 Adults Patients
| dc.contributor.author | Mosab Nouraldein Mohammed Hamad, BSC (honors), MSC1,2 | |
| dc.contributor.author | Mohammed Abdelgafoor Abdelgadir Salih, MD2 | |
| dc.contributor.author | Mohammed Omer Mohammed Hussein, BSC, MSC, PGA2 | |
| dc.contributor.author | Sufian Khalid Mohammed Nor3 | |
| dc.contributor.author | Haifaa Mohamed Saeed MD2 | |
| dc.contributor.author | Fatima Omer Mohamed BSC2 | |
| dc.date.accessioned | 2023-11-27T10:05:08Z | |
| dc.date.available | 2023-11-27T10:05:08Z | |
| dc.date.issued | 2020-11-23 | |
| dc.description.abstract | Abstract COVID.19 Pandemic is a real disaster facing the globe, and up to date its uncontrollable , due to absence of data about the real mechanism upon which this virus overcome immune system and induce lethal symptoms certainly among aged and those with low-level of immunity. MNAD hypothesis based protocol aimed to measure validity of combination Minocycline as antibiotic, N. acetyl cysteine as antioxidant, aspirin as anticoagulant and vitamin D as immune regulator to treat COVID.19 infection. This protocol opened and implemented by any institutions or health authority after permission of the corresponding author of it. | |
| dc.identifier.uri | https://ds.eaeu.edu.sd/handle/10.58971/546 | |
| dc.language.iso | other | |
| dc.publisher | جامعة الشيخ عبدالله البدري | |
| dc.title | MNAD Hypothesis Based Protocol Proposed for Treatment of COVID.19: Assessment of Minocycline, N. acetylcysteine, Aspirin & vitamin D (MNad) Theory for treatment of COVID.19 Adults Patients |